LAURA ASHER: Open Payments
NPI 1346404852 · HAZARD, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$232 in 10 payments from 8 companies in 2025. Trend: 2023 $482 · 2024 $402 · 2025 $232
Food & beverage: $232
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $54 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $51 |
| ABBVIE INC. | 1 | $27 |
| Indivior Inc. | 1 | $21 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $20 |
| Lundbeck LLC | 1 | $19 |
| Gilead Sciences, Inc. | 1 | $19 |
Products named: BREZTRI, CAPLYTA, UBRELVY, SUBLOCADE, HETLIOZ, MOUNJARO, ABILIFY ASIMTUFII.
Industry payments across KY — which companies pay providers there.
